Genetic targeting of adenoviral vectors

Molecular Therapy

Volumn 1, Issue 5, 2000, Pages 391-405

  Krasnykh, Victor N ^a   Douglas, Joanne T ^a   Van Beusechem, Victor W ^b  

^a University of Alabama at Birmingham   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; CHEMICAL STRUCTURE; GENE DOSAGE; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; PLANT GROWTH; REVIEW; VIRION; VIRUS ASSEMBLY;

ADENOVIRIDAE; GENE DOSAGE; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; MOLECULAR STRUCTURE; TROPISM; VIRION; VIRUS ASSEMBLY;

EID: 0034181044     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0062     Document Type: Review

References (184)

1. Schuler, M., Rochlitz, C., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H. U., Dalquen, P., Fritz, M. A., Swanson, S., Herrmann, R., and Huber, C. (1998). A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum. Gene Ther. 9: 2075-2082.
2. Crystal, R. G., Hirschowitz, E., Lieberman, M., Daly, J., Kazam, E., Henschke, C., Yankelevitz, D., Kemeny, N., Silverstein, R., Ohwada, A., Russi, T., Mastrangeli, A., Sanders, A., Cooke, J., and Harvey, B. G. (1997). Phase I study of direct administration of a replication deficient adenovirus vector contaning the E coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Hum. Gene Ther. 8: 985-1001.
3. Eck, S. L., Alavi, J. B., Alavi, A. Davis, A., Hackney, D., Judy, K., Mollman, J., Phillips, P. C., Wheeldon, E. B., and Wilson, J. M. (1996). Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial. Hum. Gene Ther. 7: 1465-1482.
4. Treat, J., Kaiser, L. R., Sterman, D. H., Litzky, L., Davis, A., Wilson, J. M., and S. M. Albelda (1996). Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: A phase 1 trial (BB-IND 6274). Hum. Gene Ther. 7: 2047-2057.
5. Clayman, G. L., el-Naggar, A. K., Lippman, S. M., Henderson, Y. C., Frederick, M., Merritt, J. A., Zumstein, L. A., Timmons, T. M., Liu, T. J. Ginsberg, L., Roth, J. A., Hong, W. K., Bruso, P., and Goepfert, H. (1998). Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16: 2221-2232.
6. Stewart, A. K., Lassam, N. J., Graham, F. L., Gauldie, J., Addison, C. L., Bailey, D. J., Dessureault, S., Dube, I. D., Gallenger, S., Krajden, M., Rotstein, L. E., Quirt, I. C., and Moen, R. (1997). A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma. Hum. Gene Ther. 8: 1403-1414.
7. Rosenberg, S. A., Zhai, Y., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Seipp, C. A., Einhorn, J. H., Roberts, B., and White, D. E. (1998). Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J. Natl. Cancer Inst. 90: 1894-1900.
8. Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, R. M., Hahn, R. T., Devereux, R. B., Post, M. R., Hackett, N. R., Foster, T., Grasso, T. M., Lesser, M. L., Isom, O. W., and Crystal, R. G. (1999). Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNAto individuals with clinically significant severe coronary artery disease. Circulation 100: 468-474.
9. Bellon, G., Michel-Calemard, L., Thouvenot, D., Jagneaux, V., Poitevin, F., Malcus, C., Accart, N., Layani, M. P., Aymard, M., Bernon, H., Bienvenu, J., Courtney, M., Doring, G., Gilly, B., Gilly, R., Lamy, D., Levrey, H., Morel, Y., Paulin, C., Perraud, F., Rodillon, L., Sene, C., So, S., Touraine-Moulin, F., Pavirani, A., et al. (1997). Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial. Hum. Gene Ther. 8: 15-25.
10. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59-74.
11. Fallaux, F. J., Kranenburg, O., Cramer, S. J., Houweling, A., Van Ormondt, H., Hoeben, R. C., and Van Der Elo, A. J. (1996). Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7: 215-222.
12. Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J., Hehir, K. M., Keegan, J., Auger, C., Cramer, S. J., van Ormondt, H., van der Elo, A. J., Valerio, D., and Hoeben, R. C. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9: 1909-1917.
13. Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., and Caskey, C. T. (1996). A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad Sci. USA 93: 5731-5736.
14. Fisher, K. J., Choi, H., Burda, J., Chen, S. J., and Wilson, J. M. (1996). Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217: 11-22.
15. Christ, M., Lusky, M., Stoeckel, F., Dreyer, D., Dieterle, A., Michou, A. I., Pavirani, A., and Mehtali, M. (1997). Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response. Immunol. Lett. 57: 19-25.
16. Gahery-Segard, H., Farace, F., Godfrin, D., Gaston, J., Lengagne, R., Tursz, T., Boulanger, P., and Guillet, J. G. (1998). Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J. Virol. 72: 2388-2397.
17. Kass-Eisler, A., Leinwand, L., Gall, J., Bloom, B., and Falck-Pedersen, E. (1996). Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther. 3: 154-162.
18. Jooss, K., Ertl, H. C., and Wilson, J. M. (1998). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72: 2945-2954.
19. Mishou, A. I., Santoro, L., Christ, M., Julliard, V., Pavirani, A., and Mehtali, M. (1997). Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4: 473-482.
20. Quinones, M. J., Leor, J., Kloner, R. A., Ito, M., Patterson, M., Witke, W. F., and Kedes, L. (1996). Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation 94: 1394-1401.
21. Souberbielle, B. E., and Russell, W. C. (1995). Human T cell proliferative response to polypeptides from adenovirus type 2. J. Infect. Dis. 172: 1421-1422.
22. Chirmule, N., Propert, K., Magosin, S., Qian, Y., Qian, R., and Wilson, J. (1999). Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6: 1574-1583.
23. Blackwell, J. L., Li, H., Navarro, J., Dmitriev, I., Krasnykh, V., Richter, C. A., Shaw, D. R., Alvarez, R. D., Curiel, D. T., and Strong, T. V. Circumventing inhibitory factors in ascites fluid using a tropism-modified adenoviral vector. Hum. Gene Ther., in press.
24. Mathias, P., Wickham, T., Moore, M., and Nemerow, G. (1994). Multiple adenovirus serotypes use alpha v integrins for infection. J. Virol. 68: 6811-6814.
25. Stewart, P. L., Chiu, C. Y., Huang, S., Muir, T., Zhao, Y., Chait, B., Mathias, P., and Nemerow, G. R. (1997). Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J. 16: 1189-1198.
26. Hong, J. S., and Engler, J. A. (1991). The amino terminus of the adenovirus fiber protein encodes the nuclear localization signa. Virology 185: 758-767.
27. Green, N. M., Wrigley, N. G., Russel, W. C., Martin, S. R., and McLachian, A. (1983). Evidence for a repeating cross beta sheet structure in the adenovirus fiber. EMBO J. 2: 1357-1365.
28. Stouten, P. F., Sander, C., Ruigrok, R. W., and Cusack, S. (1992). New triple-helical model for the shaft of the adenovirus fibre. J. Mol. Biol. 226: 1073-1084.
29. van Raaij, M. J., Mitraki, A., Lavigne, G., and Cusack, S. (1999). A triple beta-spiral in the adenovirus fibre shaft reveals a new structura motif for a fibrous protein. Nature 401: 935-938.
30. Chroboczek, J., Ruigrok, R. W., and Cusack, S. (1995). Adenovirus fiber. Curr. Topics Microbiol. Immunol. 199: 163-200.
31. Xia, D., Henry, L. J., Gerard, R. D., and Deisenhofer, J. (1994). Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Sructure 2: 1259-1270.
32. Xia, D., Henry, L., Gerard, R. D., and Deisenhofer, J. (1995). Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr. Topics Microbiol. Immunol. 199: 39-46.
33. van Raaij, M. J., Louis, N., Chroboczek, J., and Cusack, S. (1999). Structure of the human adenovirus serotype 2 fiber head domain at 1.5 A resolution. Virology 262: 333-343.
34. Henry, L. J., Xia, D., Wilke, M. E., Deisenhofer, J., and Gerard, R. D. (1994). Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68: 5239-5246.
35. Louis, N., Fender, P., Barge, A., Kitts, P., and Chroboczek, J. (1994). Cell-binding domain of adenovirus serotype 2 fiber. J. Virol. 68: 4104-4106.
36. Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., and Curiel, D. T. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70: 6839-6846.
37. Stevenson, S. C., Rollence, M., White, B., Weaver, L., and McClelland, A. (1995). Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J. Virol. 69: 2850-2857.
38. Wickham, T. J., Tzeng, E., Shears, L. L., Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonova, A., and Kovesdi, I. (1997). Increased in vivo and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71: 8221-8229.
39. Hong, S. S., Karayan, L., Tournier, J., Curiel, D. T., and Boulanger, P. A. (1997). Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16: 2294-2306.
40. Novelli, A., and Boulanger, P. A. (1991). Assembly of adenovirus type 2 fiber synthesized in cell-free translation system. J. Bol. Chem. 266: 9299-9303.
41. Santis, G., Legrand, V., Hong, S. S., Davison, E., Kirby, I., Imler, J. L., Finberg, R. W., Bergelson, J. M., Mehtali, M., and Boulanger, P. (1999). Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J. Gen. Virol. 80: 1519-1527.
42. Novelli, A., and Boulanger, P. A. (1991). Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185: 365-376.
43. Hong, J. S., and Engler, J. A. (1996). Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 70: 7071-7078.
44. Huang, S., Reddy, V., Dasgupta, N., and Nemerow., G. R. (1999). A single amino acid in the adenovirus type 37 fiber confers binding to human conjunctival cells. J. Virol. 73: 2798-2802.
45. Kirby, I., Davison, E., Beavil, A. J., Soh, C. P., Wickham, T. J., Roelvink, P. W., Kovesdi, I., Sutton, B. J., and Santis, G. (1999). Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J. Virol. 73: 9508-9514.
46. Roelvink, P. W., Mi Lee, G., Einfeld, D. A., Kovesdi, I., and Wickham, T. J. (1999). Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286: 1568-1571.
47. Roelvink, P. W., Lizonova, A., Lee, J. G., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I., and Wickham, T. J. (1998). The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72: 7909-7915.
48. Tomko, R. P., Xu, R., and Philipson, L. (1997). HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94: 3352-3356.
49. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
50. Davison, E., Kirby, I., Bliott, T., and Santis, G. (1999). The human HLA-A*0201 allele, expressed in hamster cells, is not a high- affinity receptor for adenovirus type 5 fiber. J. Virol. 73:4513-4517.
51. McDonald, D., Stockwin, L., Matzow, T., Zajdel, M. B., and Blair, G. (1999). Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther. 6: 1512-1519.
52. Defer, C., Belin, M. T., Caillet-Boudin, M. L., and Boulanger, P. (1990). Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C. J. Virol. 64: 3661-3673.
53. Arnberg, N., Edlund, K., Kidd, A. H., and Wadell, G. (2000). Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74: 42-48.
54. Bork, P., Holm, L., and Sander., C. (1994). The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242: 309-320.
55. Freimuth, P., Springer, K., Berard, C., Hainfeld, J., Bewley, M., and Flanagan, J. (1999). Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J. Virol. 73: 1392-1398.
56. Bewley, M. C., Springer, K., Zhang, Y. B., Freimuth, P., and Flanagan, J. M. (1999). Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR Science 286: 1579-1583.
57. Svensson, U. (1985). Role of vesicles during adenovirus 2 internalization into HeLa cells. J. Virol. 55: 442-449.
58. Wickham, T. J., Mathias, P., Cheresh, D. A., and Nemerow, G. R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
59. Wickham, T. J., Filardo, E. J., Cheresh, D. A., and Nemerow, G. R. (1994). Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127: 257-264.
60. Bai, M., Campisi, L., and Reimuth, P. (1994). Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J. Virol. 68: 5925-5932.
61. Wang, K., Huang, S., Kapoor-Munshi, A., and Nemerow, G. (1998). Adenovirus internalization and infection require dynamin. J. Virol. 72: 3455-3458.
62. Chiu, C. Y., Mathias, P., Nemerow, G. R., and Stewart, R. L. (1999). Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J. Virol. 73: 6759-6768.
63. Perez, L., and Carrasco, L. (1994). Involvement of the vacuolar H(+)-ATPase in animal virus entry. J. Gen. Virol. 75: 2595-2606.
64. Ramaswamy, H., and Hemler, M. E. (1990). Cloning, primary structure and properties of a novel human integrin beta subunit. EMBO J. 9: 1561-1568.
65. Mukherjee, S., Ghosh, R. N., and Maxfield, F. R. (1997). Endocytosis Physiol. Rev. 77: 759-803.
66. Takel, K., McPherson, P. S., Schmid, S. L., and De Camilli, P. (1995). Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals. Nature 374: 186-190.
67. Hinshaw, J. E., and Schmid, S. L. (1995). Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374: 190-192.
68. Li, E., Stupack, D., Bokoch, G. M., and Nemerow, G. R. (1998). Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72: 8806-8812.
69. Nobes, C. D., and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62.
70. Patterson, S., and Russell, W. C. (1983). Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions. J. Gen. Virol. 64: 1091-1099.
71. Leopold, P. L., Ferris, B., Grinberg, I., Worgall, S., Hackett, N. R., and Crystal, R. G. (1998). Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9: 367-378.
72. Prchla, E., Plank, C., Wagner, E., Blaas, D., and Fuchs, R. (1995). Virus-mediated release of endosomal content in vitro: Different behavior of adenovirus and rhinovirus serotype 2. J. Cell Biol. 131: 111-123.
73. Seth, P., Willingham, M. C., and Pastan, I. (1984). Adenovirus-dependent release of 51Cr from KB cells at an acidic pH. J. Biol. Chem. 259: 14350-14353.
74. Seth, P. (1994). Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J. Virol. 68: 1204-1206.
75. FitzGerald, D. J., Padmanabhan, R., Pastan, I., and Willingham, M. C. (1983). Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis. Cell 32: 607-617.
76. Dales, S., and Chardonnet, Y. (1973). Early events in the interaction of adenoviruses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum. Virology 56: 465-483.
77. Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E., and Crystal, R. G. (2000). Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11: 151-165.
78. Freimuth, P. (1996). A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor. J. Virol. 70: 4081-4085.
79. Walters, R. W., Grunst, T., Bergelson, J. M., Finberg, R. W., Welsh, M. J., and Zabner, J. (1999). Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274: 10219-10226.
80. Zabner, J., Freimuth, P., Puga, A., Fabrega, A., and Welsh, M. J. (1997). Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Invest. 100: 1144-1149.
81. Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., and Danel, C. (1994). Administration of an adenovirus contaning the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8: 42-51.
82. Hay, J. G., McElvaney, N. G., Herena, J., and Crystal, R. G. (1995). Modification of nasal epithelia potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6: 1487-1496.
83. Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P. C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., Jones, K. R., et al. (1995). A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. 333: 823-831.
84. Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., and Welsh, M. J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207-216.
85. Zabner, J., Ramsey, B. W., Meeker, D. P., Aitken, M. L., Balfour, R. P., Gibson, R. L., Launspach, J., Moscicki, R. A., Richards, S. M., Standaert, T. A., et al. (1996). Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97: 1504-1511.
86. Nalbantoglu, J., Pari, G., Karpati, G., and Holland, P. C. (1999). Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum. Gene Ther. 10: 1009-1019.
87. Huang, S., Kamata, T., Takada, Y., Ruggeri, Z. M., and Nemerow, G. R. (1996). Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70: 4502-4508.
88. Huang, S., Ehdo, R. I., and Nemerow, G. R. (1995). Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69: 2257-2263.
89. Leon, R. P., Hedlund, T., Meech, S. J., Li, S., Schaack, J., Hunger, S. P., Duke, R. C., and DeGregori, J. (1998). Adenoviral-mediated gene transfer in lymphocytes. Proc. Natl. Acad Sci. USA 95: 13159-13164.
90. Hidaka, C., Milano, E., Leopold, P. L., Bergelson, J. M., Hackett, N. R., Finberg, R. W., Wickham, T. J., Kovesdi, I., Roelvink, P., and Crystal, R. G. (1999). CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J. Clin. Invest. 103: 579-587.
91. Kaner, R. J., Worgall, S., Leopold, P. L., Stolze, E., Milano, E., Hidaka, C., Ramalingam, R., Hackett, N. R., Singh, R., Bergelson, J., Finberg, R., Falck-Pedersen, E., and Crystal, R. G. (1999). Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Am. J. Respir. Cell. Mol. Biol. 20: 361-370.
92. Tillman, B. W., Gruijl, T. D., Bakker, S. A., Scheper, R. J., Pinedo, H. M., Curiel, T. J., Gerritsen, W. R., and Curiel, D. T. (1999). Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J. Immunol. 162: 6378-6383.
93. Blackwell, J. L., Miller, C. R., Douglas, J. T., Li, H., Peters, G. E., Carroll, W. R., Strong, T. V., and Curiel, D. T. (1999). Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 125: 856-863.
94. Miller, C. R., Buchsbaum, D. J., Reynolds, P. N., Douglas, J. T., Gillespie, G. Y., Mayo, M. S., Raben, D., and Curiel, D. T. (1998). Differentia susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 58: 5738-5748.
95. Hemmi, S., Geertsen, R., Mezzacasa, A., Peter, I., and Dummer, R. (1998). The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum. Gene Ther. 9: 2363-2373.
96. Li, Y., Pong, R. C., Bergelson, J. M., Hall, M. C., Sagalowsky, A. I., Tseng, C. P., Wang, Z., and Hsieh, J. T. (1999). Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy. Cancer Res. 59: 325-330.
97. Stevenson, S. C., Pollence, M., Marshall-Neff, J., and McClelland, A. (1997). Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71: 4782-4790.
98. Zabner, J., Chillon, M., Grunst, T., Moninger, T. O., Davidson, B. L., Gregory, R., and Armentano, D. (1999). A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. J. Virol. 73: 8689-8695.
99. Von Seggern, D. J., Huang, S., Fleck, S. K., Stevenson, S. C., and Nemerow, G. R. (2000). Adenovirus vector pseudotyping in fiber-expressing cell lines: Improved transduction of Epstein-Barr virus-transformed B cells. J. Virol. 74: 354-362.
100. Segerman, A., Mei, Y. F., and Wadell, G. (2000). Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines. J. Virol. 74: 1457-1467.
101. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996). Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14: 1574-1578.
102. Watkins, S. J., Mesyanzhinov, V. V., Kurochkina, L. P., and Hawkins, R. E. (1997). The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery. Gene Ther. 4: 1004-1012.
103. Goldman, C. K., Rogers, B. E., Douglas, J. T., Sosnowski, B. A., Ying, W., Siegal, G. P., Baird, A., Campan, J. A., and Curiel, D. T. (1997). Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57: 1447-1451.
104. Wickham, T. J., Lee, G. M., Titus, J. A., Sconocchia, G., Bakacs, T., Kovesdi, I., and Sega, D. M. (1997). Targeted adenovirus-mediated gene delivery to T cells via CD3. J. Virol. 71: 7663-7669.
105. Haisma, H., Pinedo, H., Rijswijk, A., der Meulen-Muileman, I., Sosnowski, B., Ying, W., Beusechem, V., Tillman, B., Gerritsen, W., and Curiel, D. T. (1999). Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. Gene Ther. 6: 1469-1474.
106. Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., and Kovesdi, I. (1996). Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70: 6831-6838.
107. Wickham, T. J., Haskard, D., Segal, D., and Kovesdi, I. (1997). Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation. Cancer Immunol. Immunother. 45: 149-151.
108. Feng, Y., Chung, D., Garrard, L., McEnroe, G., Lim, D., Scardina, J., McFadden, K., Guzzetta, A., Lam, A., Abraham, J., Liu, D., and Endemann, G. (1998). Peptides derived from the complementarity-determining regions of anti- Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1. J. Biol. Chem. 273: 5625-5630.
109. Levi, M., Sallberg, M., Ruden, U., Herlyn, D., Maruyama, H., Wigzell, H., Marks, J., and Wahren, B. (1993). A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 90: 4374-4378.
110. Parmley, S. F., and Smith, G. P. (1988). Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes Gene 73: 305-318.
111. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., and DeGrado, W. F. (1992). Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 14: 509-515.
112. Barry, M. A., Dower, W. J., and Johnston, S. A. (1996). Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2: 299-305.
113. Doorbar, J., and Winter, G. (1994). Isolation of a peptide antagonist to the thrombin receptor using phage display. J. Mol. Biol. 244: 361-369.
114. Goodson, R. J., Doyle, M. V., Kaufman, S. E., and Rosenberg, S. (1994). High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc. Natl. Acad. Sci. USA 91: 7129-7133.
115. Arap, W., Rasqualini, R., and Ruoslahti, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380.
116. Pasqualini, R., Koivunen, E., and Ruoslahti, E. (1997). Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15: 542-546.
117. Jannot, C. B., Beerli, R. R., Mason, S., Gullick, W. J., and Hynes, N. E. (1996). Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene 13: 275-282.
118. Klimka, A., Barth, S., Matthey, B., Roovers, R. C., Lemke, H., Hansen, H., Arends, J. W., Diehl, V., Hoogenboom, H. R., and Engert, A. (1999). An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line. Br. J. Cancer 80: 1214-1222.
119. Popov, S., Hubbard, J. G., and Ward, E. S. (1996). A novel and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s). Mol. Immunol. 33: 493-502.
120. Thirion, S., Motmans, K., Heyligen, H., Janssens, J., Raus, J., and Vandevyver, C. (1996). Mono- and bispecific single-chain antibody fragments for cancer therapy. Eur. J. Cancer Prev. 5: 507-511.
121. Tsantili, P., Tzartos, S. J., and Mamalaki, A. (1999). High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor. J. Neuroimmunol. 94: 15-27.
122. Osbourn, J. K., Field, A., Wilton, J., Derbyshire, E., Earnshaw, J. C., Jones, P. T., Allen, D., and McCafferty, J. (1996). Generation of a panel of related human scFv antibodies with high affinities for human CEA. Immunotechnology 2: 181-196.
123. Proba, K., Worn, A., Honegger, A., and Pluckthun, A. (1998). Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275: 245-253.
124. Schier, R., Bye, J., Apell, G., McCall, A., Adams, G. P., Malmqvist, M., Weiner, L. M., and Marks, J. D. (1996). Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J. Mol. Biol. 255: 28-43.
125. Song, Z., Cai, Y., Song, D., Xu, J., Yuan, H., Wang, L., Zhu, X., Lin, H., Breitling, F., and Dubel, S. (1997). Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin. Hybridoma 16: 235-241.
126. Michael, S. I., Hong, J. S., Curiel, D. T., and Engler, J. A. (1995). Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2: 660-668.
127. Wickham, T. J., Roelvink, P. W., Brough, D. E., and Kovesdi, I. (1996). Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14: 1570-1573.
128. McDonald, G. A., Zhu, G., Li, Y., Kovesdi, I., Wickham, T. J., and Sukhatme, V. P. (1999). Efficient adenoviral gene transfer to kidney cortical vasculature using a fiber modified vector. J. Gene Med. 1: 103-110.
129. Yoshida, Y., Sadata, A., Zhang, W., Saito, K., Shinoura, N., and Hamada, H. (1998). Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum. Gene Ther. 9: 2503-2515.
130. Gonzalez, R., Vereecque, R., Wickham, T. J., Vanrumeke, M., Kovesdi, I., Bauters, F., Fenaux, P., and Quesnel, B. (1999). Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther. 6: 314-320.
131. Gonzalez, R., Vereecque, R., Wickham, T. J., Facon, T., Hetuin, D., Kovesdi, I., Bauters, F., Fenaux, P., and Quesnel, B. (1999). Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum. Gene Ther. 10: 2709-2717.
132. Bouri, K., Feero, W. G., Myerburg, M. M., Wickham, T. J., Kovesdi, I., Hoffman, E. P., and Clemens, P. R. (1999). Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum. Gene Ther. 10: 1633-1640.
133. van Deutekom, J. C. T., Cao, B., Pruchnic, R., Wickham, T. J., Kovesdi, I., and Huard, J. (1999). Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle. J. Gene Med. 1: 393-399.
134. Krasnykh, V., Dmitriev, I., Mikheeva, G., Miller, C. R., Belousova, N., and Curiel, D. T. (1998). Characterization of an adenovirus vector contaning a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72: 1844-1852.
135. Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., and Curiel, D. T. (1998). An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72: 9706-9713.
136. Vanderkwaak, T. J., Wang, M., Gomez-Navarro, J., Rancourt, C., Dmitriev, I., Krasnykh, V., Barnes, M., Siegal, G. P., Alvarez, R., and Curiel, D. T. (1999). An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. Gynecol. Oncol. 74: 227-234.
137. Kasono, K., Backwell, J. L., Douglas, J. T., Dmitriev, I., Strong, T. V., Reynolds, P., Kropf, D. A., Carroll, W. R., Peters, G. E., Bucy, R. T., Curiel, D. T., and Krasnykh, V. (1999). Selective gene delivery to head and neck cancer cells via an integrin targeted adenovirus vector. Clin. Cancer Res. 5: 2571-2579.
138. Krasnykh, V., and Belousova, N. Unpublished data
139. Roelvink, P. W., Kovesdi, I., and Wickham, T. J. (1996). Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J. Virol. 70: 7614-7621.
140. Legrand, V., Spehner, D., Schlesinger, Y., Settelen, N., Pavirani, A., and Mehtali, M. (1999). Rberless recombinant adenoviruses: Virus maturation and infectivity in the absence of fiber. J. Virol. 73: 907-919.
141. Von Seggern, D. J., Kehler, J., Endo, R. I., and Nemerow, G. R. (1998). Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J. Gen. Virol. 79: 1461-1468.
142. Falgout, B., and Ketner, G. (1988). Characterization of adenovirus particles made by deletion mutants lacking the fiber gene. J. Virol. 62: 622-655.
143. Miyazawa, N., Leopold, P. L., Hackett, N. R., Ferris, B., Worgall, S., Falck-Pedersen, E., and Crystal, R. G. (1999). Rber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73: 6056-6065.
144. Wickham, T. J., Carrion, M. E., and Kovesdi, I. (1995). Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750-756.
145. Athappilly, F. K., Murali, R., Rux, J. J., Cai, Z., and Burnett, R. M. (1994). The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 A resolution. J. Mol. Biol. 242: 430-455.
146. Roberts, M. M., White, J. L., Grutter, M. G., and Burnett, R. M. (1986). Three-dimensional structure of the adenovirus major coat protein hexon. Science 232: 1148-1151.
147. Rux, J. J., and Burnett, R. M. (2000). Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol. Ther.
148. van Oostrum, J., Smith, P. R., Mohraz, M., and Burnett, R. M. (1987). The structure of the adenovirus capsid. III. Hexon packing determined from electron micrographs of capsid fragments. J. Mol. Biol. 198: 73-89.
149. Hu, S., L., Hays, W. W., and Potts, D. E. (1984). Sequence homology between bovine and human adenoviruses. J. Virol. 49: 604-608.
150. Kinloch, R., Mackay, N., and Mautner, V. (1984). Adenovirus hexon. Sequence comparison of subgroup C serotypes 2 and 5. J. Biol. Chem. 259: 6431-6436.
151. Crawford-Miksza, L., and Schnurr, D. P. (1996). Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions contaning serotype-specific residues. J. Virol. 70: 1836-1844.
152. Pring-Akerblom, P., and Adrian, T. (1993). The hexon genes of adenoviruses of subgenus C: Comparison of the variable regions. Res. Virol. 144: 117-127.
153. Toogood, C. I., Murali, R., Burnett, R. M., and Hay, R. T. (1989). The adenovirus type 40 hexon: Sequence, predicted structure and relationship to other adenovirus hexons. J. Gen. Virol. 70: 3203-3214.
154. Toogood, C. I., Crompton, J., and Hay, R. T. (1992). Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J. Gen. Virol. 73: 1429-1435.
155. Weber, J. M., Cai, F., Murali, R., and Burnett, R. M. (1994). Sequence and structural analysis of m urine adenovirus type 1 hexon. J. Gen. Virol. 75: 141-147.
156. Crompton, J., Toogood, C. I.., Wallis, N., and Hay, R. T. (1994). Expression of a foreign epitope on the surface of the adenovirus hexon. J. Gen. Virol. 75: 133-139.
157. Vigne, E., Mahfouz, I., Dedieu, J. F., Brie, A., Perricaudet, M., and Yeh, P. (1999). RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J. Virol. 73: 5156-5161.
158. Von Seggern, D. J., Chiu, C. Y., Fleck, S. K. Stewart, P. L., and Nemerow, G. R. (1999). A helper-independent adenovirus vector with E1, E3, and fiber deleted: Structure and infectivity of fiberless particles. J. Virol. 73: 1601-1608.
159. Douglas, J. T., Miller, C. R., Kim, M., Dmitriev, I., Mikheeva, G., Krasnykh, V., and Curiel, D. T. (1999). A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat. Biotechnol. 17: 470-475.
160. Einfeld, D. A., Brough, D. E., Roelvink, P. W., Kovesdi, I., and Wickham, T. J. (1999). Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base. J. Virol. 73: 9130-9136.
161. Kirby, I., Davison, E., Beavil, A. J., Soh, C. P., Wickham, T. J., Roelvink, P. W., Kovesdi, I., Sutton, B. J., and Santis, G. (2000). Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J. Virol. 74: 2804-2813.
162. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80-82.
163. Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. (1992). The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11: 4313-4321.
164. Clark, E. A., and Lane, P. J. (1991). Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 9: 97-127.
165. Karpusas, M., Hsu, Y. M., Wang, J. H., Thompson, J., Lederman, S., Chess, L., and Thomas, D. (1995). 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3: 1426.
166. Mazzei, G. J,. Edgerton, M. D., Losberger, C., Lecoanet-Henchoz, S., Graber, P., Durandy, A., Gauchat, J. F., Bernard, A., Allet, B., and Bonnefoy, J. Y. (1995). Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270: 7025-7028.
167. Caux, C., Burdin, N., Galibert, L., Hermann, P., Renard, N., Servet-Delprat, C., and Banchereau, J. (1994). Functional CD40 on B lymphocytes and dendritic cells. Res. Immunol. 145: 235-239.
168. Harbury, P. B., Zhang, T., Kim, P. S., and Alber, T. (1993). A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 262: 1401-1407.
169. Hakansson, K., Lim, N. K., Hoppe, H. J., and Reid, K. B. (1999). Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure Fold Des. 7: 255-264.
170. Hoppe, H. J., Barlow, P. N., and Reid, K. B. (1994). A parallel three stranded alpha-helical bundle at the nucleation site of collagen triple-helix formation. FEBS Lett. 344: 191-195.
171. Strelkov, S. V., Tao, Y., Rossmann, M. G., Kurochkina, L. P., Shneider, M. M., and Mesyanzhinov, V. V. (1996). Preliminary crystallographic studies of bacteriophage T4 fibritin confirm a trimeric coiled-coil structure. Virology 219: 190-194.
172. Tao, Y., Strelkov, S. V., Mesyanzhinov, V. V., and Rossmann, M. G. (1997). Structure of bacteriophage T4 fibritin: A segmented coiled coil and the role of the C-terminal domain. Structure 5: 789-798.
173. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M., and Dorken, B. (1997). Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther. 4: 9-16.
174. Yee, D., McGuire, S. E., Brunner, N., Kozelsky, T. W., Allred, D. C., Chen, S. H., and Woo, S. L. (1996). Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther. 7: 1251-1257.
175. Herz, J., and Gerard, R. D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90: 2812-2816.
176. Huard, J., Lochmuller, H., Acsadi, G., Jani, A., Massie, B., and Karpati, G. (1995). The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2: 107-115.
177. Kass-Eisler, A., Falck-Pedersen, E., Eifenbein, D. H., Alvira, M., Buttrick, P. M., and Leinwand, L. A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1: 395-402.
178. Zinn, K. R., Douglas, J. T., Smyth, C. A., Liu, H. G., Wu, Q., Krasnykh, V. N., Mountz, J. D., Curiel, D. T., and Mountz, J. M. (1998). Imaging and tissue biodistribution of 99m Tc-labeled adenovirus knob (serotype 5). Gene Ther. 5: 798-808.
179. Printz, M. A., Gonzalez, A. M., Cunningham, M., Gu, D.-L., Ong, M., Pierce, G. F., and Aukerman, S. L. (2000). Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Hum. Gene Ther. 11: 191-204.
180. Reynolds, P. N., Zinn, K. R., Gavrilyuk, V. D., Balyasnikova, I. V., Rogers, B. E., Buchsbaum, D. J., Wang, M., Miletich, D. J., Grizzle, W. E., Douglas, J. T., Danilov, S. M., and Curiel, D. T. (2000). A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Submitted.
181. Reynolds, P. N., Dimitriev, I., and Curiel, D. T. (1999). Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector. Gene Ther. 6: 1336-1339.
182. Fechner, H., Haack, A., Wang, H., Wang, X., Eizema, K., Pauschinger, M., Schoemaker, R. G., van Veghel, R., Houtsmuller, A. B., Schultheiss, H.-P., Lamers, J. M. J., and Roller, W. (1999). Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6: 1520-1535.
183. Feero, W. G., Rosenblatt, J. D., Huard, J., Watkins, S. C., Epperly, M., Clemens, P. R., Kochanek, S., Glorioso, J. C., Partridge, T. A., and Hoffman, E. P. (1997). Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum. Gene Ther. 8: 371-380.
184. Stewart, P. L., and Burnett, R. M. (1995). Adenovirus structure by X-ray crystallography and electron microscopy. Curr. Topics Microbiol. Immunol. 199: 25-38.